Evidence map›Paper›PMID 38061886›Full record

ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2023

[Comparison of Quality of Life of the Patients Three Months after Uniportal 
and Multiportal Thoracoscopic Lobectomy].

Qi Zhang, Wei Dai, Xing Wei, Run Xiang, Hang Gu, Peihong Hu, Mingxin Liu, Wei Chen, Huaijun Gong, Yong Liang and 5 more

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Qi ZhangDepartment of Thoracic Surgery, Zigong Third People's Hospital, Zigong 643020, China.
Wei DaiDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of 
University of Electronic Science and Technology of China, Chengdu 610041, China.
Xing WeiDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of 
University of Electronic Science and Technology of China, Chengdu 610041, China.
Run XiangDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of 
University of Electronic Science and Technology of China, Chengdu 610041, China.
Hang GuDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of 
University of Electronic Science and Technology of China, Chengdu 610041, China.
Peihong HuDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of 
University of Electronic Science and Technology of China, Chengdu 610041, China.
Mingxin LiuDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of 
University of Electronic Science and Technology of China, Chengdu 610041, China.
Wei ChenDepartment of Thoracic Surgery, Zigong Third People's Hospital, Zigong 643020, China.
Huaijun GongDepartment of Thoracic Surgery, Zigong Third People's Hospital, Zigong 643020, China.
Yong LiangDepartment of Thoracic Surgery, Zigong Third People's Hospital, Zigong 643020, China.
Shichao ZhangDepartment of Thoracic Surgery, Zigong Third People's Hospital, Zigong 643020, China.
Weixing PengDepartment of Thoracic Surgery, Zigong Third People's Hospital, Zigong 643020, China.
Qiuling ShiDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of 
University of Electronic Science and Technology of China, Chengdu 610041, China.
Qiang LiDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of 
University of Electronic Science and Technology of China, Chengdu 610041, China.
Nanbin YuDepartment of Thoracic Surgery, Zigong Third People's Hospital, Zigong 643020, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe relationship between quality of life at three months after lung cancer surgery and different surgical approaches is remains unclear. This study aimed to compare the quality of life of patients three months after uniportal and multiportal thoracoscopic lobectomy.

methodsData from patients who underwent lung surgery at the Department of Thoracic Surgery, Sichuan Cancer Hospital between April 2021 and October 2021 were collected. The European Organization for Research and Treatment of Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) and Quality of Life Questionnaire-Lung Cancer 29 (EORTC QLQ-LC29) were used to collect quality of life data of the patients. Potential confounding factors in the baseline data were included in a multivariate regression model for adjustment, and the quality of life of the two groups three months postoperatively was compared with traditional clinical outcomes.

resultsA total of 130 lung cancer patients were included, with 57 males (43.8%) and 73 females (56.2%), and an average age of (57.1±9.5) yr. In the baseline data of the two groups, there was a statistical difference in the number of chest drainage tubes placed (P<0.001). After adjustment with the regression model, at three months postoperatively, there were no significant differences in all symptoms and functional status scores between the two groups (all P>0.05). The multiportal group had longer surgery time (120.0 min vs 85.0 min, P=0.001), postoperative hospital stay (6.0 d vs 4.0 d, P=0.020), and a higher incidence of early ≥ grade 2 complications (39.0% vs 10.1%, P=0.011) compared to the uniportal group.

conclusionsPatients undergoing uniportal and multiportal thoracoscopic lobectomy have similar quality of life at three months postoperatively. The uniportal group may have certain advantages in terms of traditional clinical outcome indicators such as operation time, postoperative hospital stay, and early postoperative complications.

Indexed as

Lung NeoplasmsFemaleHumansMalePneumonectomyPostoperative ComplicationsQuality of LifeRetrospective StudiesThoracic Surgery, Video-AssistedLung neoplasmsMultiportal thoracoscopyPatient-reported outcomesQuality of lifeUniportal thoracoscopy

Identifiers

PMID38061886
PMCPMC10714046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.